| Autor: |
Zsolt, Megyesfalvi, Nándor, Bárány, Zsuzsanna, Valkó, Edina, Bugyik, Sándor, Paku, Judit, Berta, András, Lantos, János, Fillinger, Judit, Moldvay, Krisztina, Bogos, Melinda, Rezeli, Gabriella, Gálffy, Christian, Lang, Zoltán, Lohinai, Réka, Hécz, Tímea, Lovas, Ferenc, Rényi-Vámos, Viktória, László, Balázs, Döme |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Magyar onkologia. 64(3) |
| ISSN: |
2060-0399 |
| Popis: |
Small cell lung cancer (SCLC; comprising approximately 14% of all lung cancer cases in Hungary) is an aggressive tumor type characterized by rapid growth and early metastasis. Although SCLC is a particularly malignant form of cancer, targeted therapies in its treatment have remained largely unsuccessful and thus there were no major therapeutic advances in the last three decades. SCLC was once considered a molecularly homogeneous malignancy. However, recent analyses led to the classification of neuroendocrine and molecular subtypes, based on the dominant expression of one of the following four transcriptional regulator genes: ASCL1, NEUROD1, YAP1 and POU2F3. Because these genetically and biologically distinct subtypes might contribute to therapeutic resistance, the better understanding of their biological and clinicopathological characteristics may help in the development of more effective SCLC therapies. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
